,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Hyperthermia,1,16514030
1,22.0,Tremor,1,16514030
2,22.0,Infusion related reaction,1,16514030
0,22.0,Product administration interrupted,6,16514040
0,22.0,Application site pain,1,16514065
0,22.0,Metastases to chest wall,6,16514085
1,22.0,Breast cancer recurrent,6,16514085
2,22.0,Metastases to lymph nodes,6,16514085
3,22.0,Metastases to bone,6,16514085
4,22.0,Metastases to liver,6,16514085
5,22.0,Bone marrow failure,6,16514085
6,22.0,Muscle spasms,6,16514085
0,22.0,Death,5,16514129
0,22.0,White blood cell count decreased,6,16514188
1,22.0,Asthenia,6,16514188
2,22.0,Fatigue,6,16514188
3,22.0,Lymphoedema,6,16514188
4,22.0,Cellulitis,6,16514188
5,22.0,Stomatitis,6,16514188
6,22.0,Dehydration,6,16514188
7,22.0,Renal impairment,6,16514188
0,22.0,Diarrhoea,2,16514192
1,22.0,Hypovolaemic shock,2,16514192
0,22.0,Encephalitis autoimmune,3,16514252
0,22.0,Seizure,6,16514260
0,22.0,Vomiting,1,16514307
1,22.0,Herpes zoster,1,16514307
2,22.0,Malnutrition,1,16514307
3,22.0,Decreased appetite,1,16514307
0,22.0,Acne,6,16514353
0,22.0,Delirium,6,16514365
1,22.0,Dizziness,2,16514365
0,22.0,Cardiac failure,6,16514385
1,22.0,Colonic fistula,6,16514385
2,22.0,Large intestine perforation,6,16514385
3,22.0,Urinary tract infection,6,16514385
4,22.0,Dyspnoea,6,16514385
5,22.0,Small intestinal obstruction,6,16514385
6,22.0,Fatigue,6,16514385
7,22.0,Bacteraemia,6,16514385
8,22.0,Decreased appetite,6,16514385
9,22.0,Muscular weakness,6,16514385
10,22.0,Embolism,6,16514385
11,22.0,Neuropathy peripheral,6,16514385
12,22.0,Liver function test abnormal,6,16514385
13,22.0,Urinary retention,6,16514385
14,22.0,Hypertension,6,16514385
0,22.1,Gingival swelling,6,16514388
1,22.1,Diarrhoea,2,16514388
2,22.1,Cancer pain,6,16514388
3,22.1,Vomiting,1,16514388
4,22.1,Nausea,1,16514388
5,22.1,Gingival abscess,6,16514388
6,22.1,Hypertension,2,16514388
7,22.1,Malaise,6,16514388
8,22.1,Haemoglobin decreased,6,16514388
9,22.1,Abdominal discomfort,1,16514388
10,22.1,Bone pain,2,16514388
11,22.1,Cough,2,16514388
12,22.1,Sleep disorder,2,16514388
0,22.0,Drug resistance,6,16514389
1,22.0,Malignant neoplasm progression,6,16514389
0,22.0,Haemolytic anaemia,3,16514396
1,22.0,Thrombotic microangiopathy,3,16514396
0,22.0,Product use in unapproved indication,6,16514453
1,22.0,Hypersensitivity,6,16514453
2,22.0,Laryngeal oedema,6,16514453
3,22.0,No adverse event,6,16514453
0,22.0,Delirium,3,16514460
1,22.0,Behaviour disorder,6,16514460
0,22.0,Tumour pseudoprogression,6,16514508
0,22.0,Respiratory distress,6,16514526
1,22.0,Decreased appetite,1,16514526
2,22.0,Pyrexia,1,16514526
3,22.0,Fatigue,1,16514526
4,22.0,Pneumonitis,1,16514526
0,22.0,Febrile neutropenia,3,16514534
1,22.0,Atrial fibrillation,3,16514534
0,22.0,Bone pain,6,16514558
1,22.0,Fatigue,6,16514558
2,22.0,Joint stiffness,6,16514558
3,22.0,Alopecia,6,16514558
4,22.0,Neoplasm progression,6,16514558
5,22.0,Urinary tract infection,6,16514558
6,22.0,Hot flush,6,16514558
0,22.0,Pneumocystis jirovecii pneumonia,5,16514605
0,22.0,Sepsis,5,16514608
1,22.0,Diarrhoea,5,16514608
2,22.0,Dehydration,5,16514608
0,22.0,Haemolytic anaemia,1,16514621
1,22.0,Off label use,,16514621
0,22.0,Nausea,6,16514715
1,22.0,Product use in unapproved indication,6,16514715
0,22.0,Hydronephrosis,6,16514778
1,22.0,Musculoskeletal stiffness,6,16514778
2,22.0,Hydroureter,6,16514778
3,22.0,Asthenia,6,16514778
4,22.0,Cutaneous calcification,6,16514778
5,22.0,Formication,6,16514778
6,22.0,Dyspepsia,6,16514778
7,22.0,Prostate cancer,6,16514778
8,22.0,General physical health deterioration,6,16514778
9,22.0,Haemoglobin decreased,6,16514778
0,22.1,Fatigue,6,16514796
1,22.1,Thrombosis,6,16514796
2,22.1,Prostatic specific antigen increased,6,16514796
3,22.1,Malignant neoplasm progression,6,16514796
4,22.1,Hot flush,6,16514796
0,22.0,Arthralgia,3,16514847
1,22.0,Alopecia,3,16514847
2,22.0,Fatigue,3,16514847
0,22.0,Haemorrhage,6,16514882
1,22.0,Platelet count decreased,6,16514882
0,22.0,Drug hypersensitivity,1,16514883
1,22.0,Face oedema,1,16514883
2,22.0,Hypertension,1,16514883
3,22.0,Tongue oedema,1,16514883
4,22.0,Fear,1,16514883
5,22.0,Abdominal pain,1,16514883
6,22.0,Pruritus,1,16514883
7,22.0,Tachycardia,1,16514883
8,22.0,Dyspnoea,1,16514883
9,22.0,Chest pain,1,16514883
10,22.0,Anxiety,1,16514883
0,22.0,Neoplasm progression,6,16514900
0,22.0,Malignant neoplasm progression,6,16515612
1,22.0,Death,5,16515612
0,22.0,Fournier^s gangrene,6,16515635
0,22.1,Stress,2,16515873
1,22.1,Full blood count decreased,1,16515873
2,22.1,Cataract,2,16515873
3,22.1,Post procedural infection,6,16515873
4,22.1,Asthenia,1,16515873
5,22.1,Malaise,1,16515873
0,22.1,Walking aid user,6,16515899
1,22.1,Loss of personal independence in daily activities,6,16515899
2,22.1,Blood count abnormal,6,16515899
0,22.0,Facial spasm,,16516304
1,22.0,Blood pressure increased,,16516304
2,22.0,Swelling,,16516304
3,22.0,Dysphagia,,16516304
4,22.0,Swelling face,,16516304
0,22.0,Hypoaesthesia,,16516324
0,22.0,Death,,16516386
0,22.1,Hallucination,6,16516454
1,22.1,Neuralgia,6,16516454
2,22.1,Cognitive disorder,6,16516454
3,22.1,Dizziness,6,16516454
4,22.1,Chills,6,16516454
5,22.1,Arthralgia,6,16516454
6,22.1,Tetany,6,16516454
7,22.1,Muscle contracture,6,16516454
8,22.1,Paraesthesia,6,16516454
9,22.1,Vomiting,6,16516454
10,22.1,Menorrhagia,6,16516454
11,22.1,Pain in extremity,6,16516454
12,22.1,Sensory loss,6,16516454
13,22.1,Tooth disorder,6,16516454
14,22.1,Muscle spasms,6,16516454
15,22.1,Insomnia,6,16516454
16,22.1,Mucosal toxicity,6,16516454
17,22.1,Facial pain,6,16516454
18,22.1,Visual acuity reduced,6,16516454
19,22.1,Hot flush,6,16516454
20,22.1,Platelet count decreased,6,16516454
21,22.1,Emotional disorder,6,16516454
22,22.1,Weight increased,2,16516454
23,22.1,Tinnitus,6,16516454
24,22.1,Pain,6,16516454
25,22.1,Herpes zoster,6,16516454
26,22.1,Hepatocellular injury,2,16516454
27,22.1,Pathological fracture,6,16516454
28,22.1,Vulvovaginal dryness,6,16516454
29,22.1,Dysstasia,6,16516454
30,22.1,Gait disturbance,6,16516454
31,22.1,Visual impairment,6,16516454
32,22.1,Nausea,6,16516454
33,22.1,Skin sensitisation,6,16516454
34,22.1,Loss of libido,6,16516454
35,22.1,Depressive symptom,6,16516454
36,22.1,Skin toxicity,6,16516454
37,22.1,Fatigue,6,16516454
38,22.1,Disturbance in attention,6,16516454
39,22.1,Neuropathy peripheral,6,16516454
40,22.1,Gingival pain,6,16516454
41,22.1,Ageusia,6,16516454
42,22.1,Periostitis,6,16516454
0,22.0,Hypoglycaemia,1,16516686
1,22.0,Drug interaction,1,16516686
0,22.0,Osteonecrosis of jaw,6,16516688
1,22.0,Jaw fracture,6,16516688
2,22.0,Fistula,6,16516688
0,22.0,Hypoglycaemia,6,16516696
1,22.0,Drug interaction,6,16516696
0,22.0,Diarrhoea,2,16516952
1,22.0,Hypotension,3,16516952
2,22.0,Vomiting,2,16516952
3,22.0,Dehydration,3,16516952
4,22.0,Asthenia,2,16516952
5,22.0,Dizziness,3,16516952
0,22.0,Muscle atrophy,3,16516968
1,22.0,Metastatic neoplasm,6,16516968
0,22.0,Flushing,1,16517370
1,22.0,Dyspnoea,1,16517370
2,22.0,Sinus tachycardia,1,16517370
3,22.0,Hypertension,1,16517370
4,22.0,Drug hypersensitivity,1,16517370
0,22.0,Neuropathy peripheral,2,16517373
0,22.0,Hypoxia,1,16517377
1,22.0,Drug hypersensitivity,1,16517377
2,22.0,Hypotension,1,16517377
3,22.0,Nausea,1,16517377
0,22.0,Drug resistance,6,16517540
1,22.0,Malignant neoplasm progression,6,16517540
0,22.0,Death,,16517597
0,22.0,Neoplasm progression,6,16517665
1,22.0,Neuropathy peripheral,6,16517665
0,22.0,Dehydration,,16517842
0,22.0,Hypersensitivity pneumonitis,6,16518050
0,22.0,Product use in unapproved indication,6,16518062
1,22.0,Off label use,6,16518062
2,22.0,Neurotoxicity,2,16518062
0,22.1,Off label use,6,16518069
1,22.1,Rash erythematous,2,16518069
2,22.1,Product use in unapproved indication,6,16518069
3,22.1,Skin hyperpigmentation,2,16518069
0,22.1,Proteinuria,4,16518109
1,22.1,Blood triglycerides increased,2,16518109
2,22.1,Haematuria,4,16518109
3,22.1,Glomerular filtration rate decreased,6,16518109
4,22.1,Tachycardia,3,16518109
5,22.1,Dizziness,1,16518109
6,22.1,Renal impairment,4,16518109
7,22.1,Blood cholesterol increased,6,16518109
8,22.1,Fibrin D dimer increased,3,16518109
0,22.0,Fatigue,3,16518118
0,22.1,Transient ischaemic attack,6,16518131
1,22.1,Pyrexia,6,16518131
2,22.1,Fatigue,3,16518131
3,22.1,Neoplasm progression,5,16518131
4,22.1,Hallucination,3,16518131
5,22.1,Condition aggravated,3,16518131
6,22.1,Diarrhoea,2,16518131
7,22.1,Dyspnoea,3,16518131
0,22.0,Delirium,6,16518197
0,22.1,Arthritis,6,16518264
0,22.1,Neutropenia,6,16518320
1,22.1,Nasopharyngitis,6,16518320
0,22.1,Rash,6,16518411
1,22.1,Second primary malignancy,6,16518411
2,22.1,Malaise,6,16518411
3,22.1,Nasopharyngitis,6,16518411
4,22.1,Cough,6,16518411
5,22.1,Lung neoplasm malignant,6,16518411
0,22.1,Hair colour changes,3,16518427
1,22.1,Madarosis,3,16518427
2,22.1,Hair disorder,3,16518427
3,22.1,Alopecia,3,16518427
4,22.1,Hair texture abnormal,3,16518427
0,22.1,Alopecia,3,16518435
1,22.1,Hair disorder,3,16518435
2,22.1,Hair texture abnormal,3,16518435
3,22.1,Hair colour changes,3,16518435
0,22.0,Adverse event,6,16518439
1,22.0,Product use in unapproved indication,6,16518439
0,22.0,Product use in unapproved indication,6,16518442
1,22.0,Rash,3,16518442
0,22.0,Drug resistance,6,16518633
1,22.0,Malignant neoplasm progression,6,16518633
0,22.0,Hypoxia,1,16518776
1,22.0,Anxiety,1,16518776
2,22.0,Nausea,1,16518776
3,22.0,Sinus tachycardia,1,16518776
4,22.0,Dizziness,1,16518776
5,22.0,Dyspnoea,1,16518776
6,22.0,Drug hypersensitivity,1,16518776
7,22.0,Hypertension,1,16518776
0,22.0,Prostate cancer,6,16518902
1,22.0,Drug diversion,6,16518902
0,22.0,Malignant neoplasm progression,6,16518975
1,22.0,Drug resistance,6,16518975
0,22.0,Neoplasm malignant,6,16518980
1,22.0,Vomiting,6,16518980
2,22.0,Rhinorrhoea,6,16518980
3,22.0,Diarrhoea,6,16518980
4,22.0,Decreased appetite,6,16518980
5,22.0,Neutropenia,6,16518980
6,22.0,Arthralgia,6,16518980
7,22.0,Oropharyngeal pain,6,16518980
8,22.0,Therapeutic product effect decreased,6,16518980
9,22.0,Tumour marker increased,6,16518980
10,22.0,Product dose omission,6,16518980
11,22.0,Red blood cell count decreased,6,16518980
12,22.0,Tumour flare,6,16518980
13,22.0,Abdominal discomfort,6,16518980
14,22.0,White blood cell count decreased,6,16518980
15,22.0,Lacrimation increased,6,16518980
0,22.0,Product administration error,6,16519167
0,22.0,Pneumonitis,1,16519251
0,22.0,Adrenal disorder,2,16519253
0,22.0,Ileus,1,16519275
0,22.0,Death,5,16519292
0,22.0,Haemorrhoids,6,16519337
1,22.0,Bowel movement irregularity,6,16519337
2,22.0,Asthenia,6,16519337
3,22.0,Diarrhoea,3,16519337
4,22.0,Weight decreased,3,16519337
5,22.0,Diarrhoea haemorrhagic,6,16519337
6,22.0,Decreased appetite,2,16519337
7,22.0,Death,5,16519337
8,22.0,Fatigue,2,16519337
0,22.0,Drug interaction,6,16519338
1,22.0,Therapeutic response decreased,6,16519338
2,22.0,Malignant neoplasm progression,6,16519338
3,22.0,Pain,2,16519338
0,22.0,Hospitalisation,1,16519503
1,22.0,Palliative care,3,16519503
2,22.0,Death,5,16519503
3,22.0,Prostate cancer metastatic,3,16519503
0,22.0,Erythema multiforme,2,16519585
1,22.0,Cytopenia,2,16519585
0,22.0,Malignant neoplasm progression,5,16519586
0,22.0,Abdominal pain upper,2,16519952
1,22.0,Retching,2,16519952
2,22.0,Dyspepsia,2,16519952
3,22.0,Throat tightness,2,16519952
4,22.0,Flushing,2,16519952
5,22.0,Cough,2,16519952
0,22.0,Sepsis,5,16519953
1,22.0,Peritonitis,3,16519953
2,22.0,Nausea,3,16519953
3,22.0,Intestinal perforation,3,16519953
4,22.0,Vomiting,3,16519953
0,22.0,Malaise,6,16519969
0,22.0,Febrile neutropenia,6,16520046
1,22.0,Dysphagia,2,16520046
2,22.0,Decreased appetite,2,16520046
3,22.0,Asthenia,2,16520046
4,22.0,Abdominal pain,1,16520046
0,22.0,Visual acuity reduced,2,16520049
0,22.0,Death,5,16520071
0,22.0,Cerebrovascular accident,6,16520079
0,22.0,Nausea,3,16520087
1,22.0,Dysphagia,2,16520087
2,22.0,Decreased appetite,3,16520087
3,22.0,Speech disorder,2,16520087
4,22.0,Condition aggravated,,16520087
5,22.0,Oropharyngeal pain,2,16520087
6,22.0,Feeding disorder,,16520087
7,22.0,Asthenia,,16520087
8,22.0,Off label use,,16520087
0,22.0,Seizure,1,16520091
1,22.0,Lethargy,1,16520091
2,22.0,Pruritus,1,16520091
3,22.0,Erythema,1,16520091
4,22.0,Syncope,1,16520091
5,22.0,Blood pressure decreased,1,16520091
6,22.0,Infusion related reaction,1,16520091
0,22.0,Osteoarthritis,3,16520129
1,22.0,Osteonecrosis,3,16520129
2,22.0,Pain,3,16520129
0,22.0,Skin toxicity,6,16520145
1,22.0,Liver function test increased,6,16520145
0,22.0,Malignant neoplasm progression,6,16520225
1,22.0,Drug ineffective,6,16520225
2,22.0,Drug-induced liver injury,6,16520225
0,22.0,Malignant neoplasm progression,5,16520231
1,22.0,Treatment failure,5,16520231
0,22.0,Renal failure,5,16520284
1,22.0,Febrile neutropenia,5,16520284
2,22.0,Bone marrow failure,5,16520284
0,22.0,Oral infection,6,16520285
1,22.0,Tooth loss,6,16520285
2,22.0,Osteonecrosis of jaw,3,16520285
3,22.0,Toothache,6,16520285
0,22.0,Pain,3,16520328
1,22.0,Pneumonia,3,16520328
2,22.0,Feeding disorder,3,16520328
3,22.0,Pyrexia,3,16520328
4,22.0,Pain,3,16520328
5,22.0,Weight decreased,,16520328
6,22.0,Dehydration,3,16520328
7,22.0,Dry skin,3,16520328
8,22.0,Pain in extremity,3,16520328
9,22.0,Localised infection,,16520328
10,22.0,Chills,1,16520328
11,22.0,Ill-defined disorder,1,16520328
12,22.0,Skin fissures,3,16520328
13,22.0,Peripheral swelling,3,16520328
14,22.0,Dermatitis acneiform,3,16520328
15,22.0,Blister,,16520328
16,22.0,Gait disturbance,3,16520328
0,22.0,Emotional distress,6,16520409
1,22.0,Alopecia,3,16520409
2,22.0,Anxiety,6,16520409
3,22.0,Pain,6,16520409
4,22.0,Impaired quality of life,6,16520409
5,22.0,Psychological trauma,6,16520409
0,22.0,Hormone-refractory prostate cancer,3,16520743
1,22.0,Bone marrow failure,6,16520743
0,22.0,Hormone-refractory prostate cancer,3,16520744
1,22.0,Back pain,3,16520744
0,22.0,Seizure,2,16520844
1,22.0,Vomiting,2,16520844
2,22.0,Nausea,3,16520844
3,22.0,Hyponatraemia,1,16520844
4,22.0,Chest pain,1,16520844
5,22.0,Back pain,2,16520844
6,22.0,Dyspnoea,2,16520844
0,22.0,Asthenia,3,16520872
0,22.1,Decreased appetite,2,16521103
1,22.1,Malaise,2,16521103
0,22.1,Hyponatraemia,1,16521125
0,22.0,Dermatitis bullous,3,16521131
1,22.0,Peripheral sensory neuropathy,3,16521131
2,22.0,Anaemia,1,16521131
3,22.0,Nail bed inflammation,3,16521131
4,22.0,Diarrhoea,3,16521131
5,22.0,Constipation,3,16521131
6,22.0,Skin fissures,3,16521131
7,22.0,Rhinitis,3,16521131
8,22.0,Dermatitis,3,16521131
0,22.0,Focal nodular hyperplasia,1,16521134
0,22.1,Lung disorder,6,16521159
0,22.0,Death,5,16521246
1,22.0,Intentional product use issue,6,16521246
0,22.0,Artificial crown procedure,6,16521326
1,22.0,Osteonecrosis of jaw,6,16521326
0,22.0,Superinfection,2,16521383
1,22.0,Cellulitis,1,16521383
2,22.0,Vomiting,3,16521383
3,22.0,Nausea,3,16521383
4,22.0,Headache,3,16521383
5,22.0,Ejection fraction decreased,3,16521383
6,22.0,Cough,1,16521383
7,22.0,Abdominal pain lower,1,16521383
8,22.0,Lower respiratory tract infection,1,16521383
9,22.0,Swelling face,3,16521383
10,22.0,Asthenia,3,16521383
11,22.0,Mouth swelling,6,16521383
12,22.0,Urinary tract infection,3,16521383
13,22.0,Abdominal pain,3,16521383
14,22.0,Headache,1,16521383
15,22.0,Pain in extremity,3,16521383
0,22.0,Breast haematoma,1,16521385
0,22.0,Hepatocellular injury,1,16521418
1,22.0,Drug interaction,6,16521418
0,22.0,Bone marrow failure,6,16521454
1,22.0,Lower respiratory tract infection,6,16521454
2,22.0,Pain,6,16521454
3,22.0,Arthralgia,3,16521454
4,22.0,Urinary tract infection bacterial,6,16521454
5,22.0,Fatigue,3,16521454
6,22.0,Pruritus,3,16521454
7,22.0,Bone pain,3,16521454
8,22.0,White blood cell count decreased,6,16521454
9,22.0,Nasopharyngitis,6,16521454
10,22.0,Pyrexia,1,16521454
11,22.0,Hepatic enzyme increased,6,16521454
0,22.0,Neutropenia,6,16521512
1,22.0,Leukopenia,6,16521512
0,22.1,Alopecia,3,16521529
0,22.0,Paralysis,3,16521556
0,22.0,Drug resistance,6,16521567
1,22.0,Malignant neoplasm progression,6,16521567
0,22.0,Febrile neutropenia,6,16521678
1,22.0,Tuberculosis,5,16521678
0,22.0,Gastrointestinal haemorrhage,2,16521687
1,22.0,Thrombocytopenia,3,16521687
2,22.0,Blood loss anaemia,2,16521687
0,22.0,Dysstasia,6,16521689
1,22.0,Fall,6,16521689
2,22.0,Asthenia,6,16521689
3,22.0,Gait disturbance,6,16521689
0,22.0,Transaminases increased,6,16521758
1,22.0,Blood calcium decreased,6,16521758
2,22.0,Haemoglobin decreased,6,16521758
3,22.0,Pyrexia,6,16521758
4,22.0,Blood phosphorus decreased,6,16521758
5,22.0,Dehydration,5,16521758
6,22.0,Diarrhoea,5,16521758
7,22.0,Confusional state,6,16521758
8,22.0,Renal failure,5,16521758
9,22.0,Diabetes mellitus,5,16521758
10,22.0,Cardiac failure,5,16521758
11,22.0,Hypertension,5,16521758
12,22.0,Aspartate aminotransferase increased,6,16521758
13,22.0,Pneumonia,5,16521758
14,22.0,Alanine aminotransferase increased,6,16521758
0,22.0,Death,5,16521820
0,22.1,Hair texture abnormal,3,16521863
1,22.1,Alopecia,3,16521863
2,22.1,Hair disorder,3,16521863
3,22.1,Hair colour changes,3,16521863
0,22.0,Febrile neutropenia,1,16521869
0,22.0,Haemorrhoids,6,16521941
1,22.0,Diarrhoea,6,16521941
2,22.0,Skin irritation,6,16521941
3,22.0,Skin discolouration,6,16521941
4,22.0,Rash,6,16521941
5,22.0,Liver disorder,6,16521941
6,22.0,Vulvovaginal discomfort,6,16521941
0,22.1,Electrocardiogram QT prolonged,1,16521947
1,22.1,Herpes zoster,1,16521947
2,22.1,Breast cancer metastatic,2,16521947
3,22.1,Sinusitis,1,16521947
4,22.1,Skin haemorrhage,1,16521947
5,22.1,Rash,3,16521947
6,22.1,Osteoarthritis,3,16521947
7,22.1,Nausea,3,16521947
8,22.1,Malignant neoplasm progression,2,16521947
9,22.1,Lacrimation increased,3,16521947
10,22.1,Headache,1,16521947
11,22.1,Gingival bleeding,1,16521947
12,22.1,Platelet count decreased,2,16521947
13,22.1,Vomiting,1,16521947
14,22.1,General physical health deterioration,1,16521947
15,22.1,Breast pain,1,16521947
16,22.1,Haemoptysis,1,16521947
0,22.0,Extravasation,2,16521974
0,22.0,Thrombocytopenia,6,16522000
1,22.0,Cough,6,16522000
2,22.0,Hyperglycaemia,6,16522000
3,22.0,Hypercholesterolaemia,6,16522000
4,22.0,Peripheral sensory neuropathy,6,16522000
5,22.0,Anxiety,6,16522000
6,22.0,Hypophosphataemia,6,16522000
7,22.0,Aspartate aminotransferase increased,6,16522000
8,22.0,Alanine aminotransferase increased,6,16522000
9,22.0,Dyspnoea,6,16522000
10,22.0,Hypoalbuminaemia,6,16522000
11,22.0,Decreased appetite,6,16522000
12,22.0,Hyponatraemia,6,16522000
13,22.0,Myalgia,6,16522000
14,22.0,Leukopenia,6,16522000
15,22.0,Dizziness,6,16522000
16,22.0,Therapeutic product effect incomplete,6,16522000
17,22.0,Neutropenia,6,16522000
18,22.0,Anaemia,6,16522000
19,22.0,Hypertriglyceridaemia,6,16522000
20,22.0,Hypertension,6,16522000
21,22.0,Fatigue,6,16522000
22,22.0,Skin toxicity,6,16522000
23,22.0,Hypomagnesaemia,6,16522000
24,22.0,Disease progression,6,16522000
25,22.0,International normalised ratio increased,6,16522000
26,22.0,Depressed mood,6,16522000
27,22.0,Nausea,6,16522000
28,22.0,Blood alkaline phosphatase increased,6,16522000
29,22.0,Alopecia,6,16522000
30,22.0,Diarrhoea,6,16522000
31,22.0,Lymphopenia,6,16522000
32,22.0,Constipation,6,16522000
33,22.0,Hypocalcaemia,6,16522000
34,22.0,Stomatitis,6,16522000
35,22.0,Arthralgia,6,16522000
0,22.0,Pulmonary toxicity,1,16522085
0,22.0,Pyrexia,6,16522087
1,22.0,Alopecia,6,16522087
2,22.0,Nausea,6,16522087
3,22.0,Rash,6,16522087
4,22.0,Tumour marker increased,6,16522087
5,22.0,Bone marrow failure,6,16522087
6,22.0,Asthenia,6,16522087
7,22.0,Diarrhoea,6,16522087
8,22.0,Proteinuria,3,16522087
9,22.0,Septic shock,2,16522087
10,22.0,Lung infection,6,16522087
11,22.0,Pneumonia,2,16522087
12,22.0,Respiratory failure,2,16522087
13,22.0,Vomiting,6,16522087
14,22.0,Mouth ulceration,6,16522087
0,22.0,Hot flush,1,16522131
1,22.0,Bone pain,1,16522131
2,22.0,Musculoskeletal stiffness,1,16522131
3,22.0,Depression suicidal,1,16522131
0,22.0,Abdominal pain,3,16522172
1,22.0,Frequent bowel movements,3,16522172
2,22.0,Flatulence,3,16522172
3,22.0,Pyrexia,3,16522172
4,22.0,Diarrhoea,3,16522172
0,22.0,Tooth loss,6,16522210
1,22.0,Tooth fracture,6,16522210
0,22.0,Tremor,6,16522345
0,22.1,Cough,6,16522352
1,22.1,Oral discomfort,6,16522352
2,22.1,Blood potassium increased,6,16522352
3,22.1,Constipation,6,16522352
4,22.1,Stomatitis,6,16522352
0,22.1,Therapeutic response unexpected,6,16522355
1,22.1,Pre-existing condition improved,6,16522355
0,22.0,Neoplasm progression,6,16522392
0,22.0,Nasopharyngitis,3,16522395
0,22.1,Blood test abnormal,6,16522411
0,22.1,Wrist fracture,1,16522423
0,22.0,Bronchitis,1,16522426
1,22.0,Diarrhoea,1,16522426
0,22.0,Gastric disorder,3,16522449
1,22.0,Vomiting,3,16522449
2,22.0,Nausea,3,16522449
0,22.0,Feeding disorder,6,16522489
1,22.0,Off label use,6,16522489
2,22.0,Hepatic neoplasm,6,16522489
3,22.0,Disease progression,3,16522489
4,22.0,Drug ineffective,6,16522489
0,22.1,Neoplasm progression,6,16522569
0,22.0,Extravasation,2,16522593
0,22.0,Pneumonia,1,16522597
0,22.0,Neutropenia,2,16522605
1,22.0,Leukopenia,2,16522605
0,22.1,Encephalitis,5,16522717
0,22.0,Platelet count decreased,5,16522747
1,22.0,Disseminated intravascular coagulation,5,16522747
2,22.0,Drug eruption,5,16522747
3,22.0,Intestinal ischaemia,5,16522747
4,22.0,Acute kidney injury,5,16522747
0,22.0,Malignant neoplasm progression,5,16522796
0,22.0,Skin toxicity,1,16522806
0,22.0,Gait disturbance,6,16522899
1,22.0,Metastases to meninges,3,16522899
2,22.0,Language disorder,6,16522899
0,22.0,Palpitations,6,16522913
0,22.0,Gastric ulcer,3,16523013
1,22.0,Abdominal pain upper,3,16523013
2,22.0,Pneumonia,3,16523013
0,22.0,Drug interaction,6,16523140
1,22.0,Hyperkalaemia,1,16523140
2,22.0,Cardio-respiratory arrest,1,16523140
3,22.0,Acute kidney injury,1,16523140
4,22.0,Metabolic acidosis,1,16523140
0,22.0,Nausea,2,16523147
1,22.0,Bronchospasm,2,16523147
2,22.0,Laryngospasm,2,16523147
3,22.0,Vomiting,2,16523147
0,22.0,Neutropenia,2,16523270
1,22.0,Leukopenia,2,16523270
0,22.0,Disease progression,6,16523349
0,22.0,Febrile neutropenia,5,16523366
0,22.1,Arteriosclerosis,6,16523379
1,22.1,Malignant neoplasm progression,6,16523379
2,22.1,Atypical pneumonia,5,16523379
3,22.1,Malignant pleural effusion,6,16523379
4,22.1,Atelectasis,6,16523379
5,22.1,Lymphangiosis carcinomatosa,5,16523379
6,22.1,Pleural calcification,6,16523379
7,22.1,Interstitial lung disease,5,16523379
8,22.1,Staphylococcus test positive,6,16523379
9,22.1,Pneumonia bacterial,5,16523379
10,22.1,Pleurisy,5,16523379
0,22.1,Interstitial lung disease,6,16523380
1,22.1,Radiation pneumonitis,2,16523380
0,22.1,Diarrhoea,1,16523454
1,22.1,Lethargy,1,16523454
2,22.1,Abdominal pain,1,16523454
3,22.1,Rash,3,16523454
4,22.1,Swollen tongue,1,16523454
5,22.1,Neuropathy peripheral,1,16523454
6,22.1,Musculoskeletal pain,3,16523454
7,22.1,Insomnia,1,16523454
8,22.1,Back pain,1,16523454
9,22.1,Vomiting,1,16523454
0,22.0,Asthenia,6,16523471
1,22.0,Diarrhoea,6,16523471
2,22.0,Gastrointestinal disorder,6,16523471
3,22.0,Bone marrow failure,1,16523471
4,22.0,Jaundice,6,16523471
5,22.0,Lung infection,6,16523471
0,22.0,Paronychia,6,16523483
1,22.0,Ascites,6,16523483
2,22.0,Pulmonary embolism,6,16523483
3,22.0,Pleural effusion,6,16523483
4,22.0,Ejection fraction decreased,6,16523483
0,22.0,Deep vein thrombosis,6,16523493
1,22.0,Fatigue,6,16523493
0,22.0,Cardiotoxicity,6,16523523
1,22.0,Hepatotoxicity,6,16523523
2,22.0,Bone marrow failure,6,16523523
0,22.0,Thermal burn,6,16523568
1,22.0,Foot fracture,6,16523568
2,22.0,Off label use,6,16523568
0,22.0,Death,5,16523569
0,22.1,Anaemia,3,16523600
0,22.0,Death,5,16523625
0,22.0,Death,5,16523666
0,22.0,Inflammation,6,16523671
1,22.0,Multiple organ dysfunction syndrome,6,16523671
2,22.0,Hepatic haemorrhage,6,16523671
3,22.0,Abdominal pain upper,6,16523671
0,22.0,Anaemia,1,16523710
1,22.0,Thrombocytopenia,1,16523710
0,22.1,Dizziness,6,16523730
1,22.1,Obsessive-compulsive disorder,6,16523730
2,22.1,Neoplasm progression,6,16523730
3,22.1,Anxiety disorder,6,16523730
0,22.1,Pyrexia,1,16523739
1,22.1,White blood cell count decreased,1,16523739
2,22.1,Vomiting,1,16523739
3,22.1,Neutropenia,1,16523739
4,22.1,Nausea,1,16523739
5,22.1,Feeling abnormal,1,16523739
6,22.1,Insomnia,6,16523739
7,22.1,Malaise,6,16523739
0,22.0,Infusion site pain,2,16523743
1,22.0,Pain in extremity,2,16523743
2,22.0,Paraesthesia,2,16523743
3,22.0,Paraesthesia oral,2,16523743
0,22.1,Decreased appetite,1,16523747
1,22.1,Pyrexia,3,16523747
2,22.1,Pneumonia,1,16523747
3,22.1,Peripheral sensory neuropathy,3,16523747
4,22.1,Neuropathy peripheral,2,16523747
5,22.1,Dyspnoea,2,16523747
6,22.1,Fatigue,2,16523747
7,22.1,Back pain,1,16523747
8,22.1,Alopecia,1,16523747
9,22.1,Pain in extremity,1,16523747
10,22.1,Fungal infection,1,16523747
11,22.1,Vascular device infection,1,16523747
12,22.1,Nasopharyngitis,1,16523747
13,22.1,Nausea,6,16523747
14,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,16523747
15,22.1,Diarrhoea,2,16523747
16,22.1,Pain,6,16523747
17,22.1,Constipation,1,16523747
18,22.1,Gastrooesophageal reflux disease,6,16523747
19,22.1,Lower respiratory tract infection,1,16523747
20,22.1,Cellulitis,1,16523747
21,22.1,Headache,1,16523747
22,22.1,Stomatitis,3,16523747
0,22.0,Radius fracture,1,16523748
1,22.0,Humerus fracture,1,16523748
2,22.0,Fall,1,16523748
3,22.0,Peripheral nerve lesion,1,16523748
0,22.0,Neutropenia,6,16523827
1,22.0,Pleural effusion,6,16523827
2,22.0,Pancytopenia,6,16523827
3,22.0,Haematotoxicity,6,16523827
4,22.0,Ejection fraction decreased,6,16523827
0,22.1,Pneumonitis,2,16524068
1,22.1,Malignant neoplasm progression,5,16524068
2,22.1,Respiratory failure,6,16524068
0,22.1,Vomiting,1,16524192
1,22.1,Colitis,1,16524192
0,22.0,Drug resistance,6,16524281
1,22.0,Malignant neoplasm progression,6,16524281
0,22.0,Malignant neoplasm progression,6,16524298
1,22.0,Drug resistance,6,16524298
0,22.1,Pain,6,16524454
1,22.1,White blood cell count decreased,6,16524454
2,22.1,Pulmonary thrombosis,6,16524454
0,22.0,Decreased appetite,6,16524485
1,22.0,Colon cancer,5,16524485
2,22.0,Intestinal obstruction,6,16524485
3,22.0,Neuropathy peripheral,6,16524485
0,22.1,Dyspepsia,3,16524494
1,22.1,Vomiting,3,16524494
2,22.1,Anxiety,3,16524494
3,22.1,Hypoacusis,3,16524494
4,22.1,Nausea,3,16524494
5,22.1,Vertigo,3,16524494
0,22.0,Neoplasm progression,5,16524556
1,22.0,Off label use,6,16524556
2,22.0,Product use in unapproved indication,6,16524556
0,22.0,Death,5,16524661
0,22.0,Neoplasm progression,5,16524673
0,22.0,Upper limb fracture,1,16524686
1,22.0,Diarrhoea,1,16524686
2,22.0,Haematochezia,1,16524686
3,22.0,Abdominal distension,1,16524686
0,22.0,Diarrhoea,1,16524865
1,22.0,Rectal haemorrhage,1,16524865
2,22.0,Diarrhoea haemorrhagic,1,16524865
0,22.0,Renal impairment,6,16524880
1,22.0,Neutropenia,6,16524880
2,22.0,Hepatic function abnormal,6,16524880
0,22.0,Spinal laminectomy,2,16524920
1,22.0,Blood testosterone decreased,3,16524920
2,22.0,Spinal stenosis,3,16524920
3,22.0,Vitamin D decreased,3,16524920
0,22.0,Left ventricular dysfunction,6,16525000
1,22.0,Febrile neutropenia,1,16525000
2,22.0,Neuropathy peripheral,1,16525000
3,22.0,Mucosal inflammation,1,16525000
4,22.0,Cardiotoxicity,1,16525000
5,22.0,Urinary tract infection,1,16525000
0,22.0,Death,5,16525046
0,22.0,Death,5,16525051
0,22.0,Death,5,16525059
0,22.0,Limb mass,6,16525066
0,22.0,Product use in unapproved indication,6,16525073
1,22.0,Cancer pain,2,16525073
0,22.0,Intestinal perforation,5,16525090
0,22.0,Alanine aminotransferase increased,6,16525093
1,22.0,Fatigue,6,16525093
2,22.0,Hypertension,6,16525093
3,22.0,Aspartate aminotransferase increased,6,16525093
4,22.0,Diabetes mellitus,6,16525093
0,22.0,Thrombocytopenia,6,16525218
1,22.0,Thrombocytopenia,2,16525218
0,22.0,Weight decreased,6,16525231
1,22.0,Haematoma,2,16525231
2,22.0,Pulmonary embolism,2,16525231
3,22.0,Dyspnoea,2,16525231
4,22.0,Aortic aneurysm,2,16525231
5,22.0,Abdominal pain,2,16525231
6,22.0,Pyrexia,2,16525231
0,22.0,Decreased appetite,1,16525278
1,22.0,Tumour marker increased,6,16525278
2,22.0,Metastases to bone,6,16525278
0,22.0,Cerebral haemorrhage,6,16525398
0,22.0,Tooth extraction,6,16525420
1,22.0,Osteonecrosis of jaw,6,16525420
0,22.0,Malignant neoplasm progression,6,16525450
1,22.0,Drug resistance,6,16525450
2,22.0,Hypertension,6,16525450
0,22.0,Vasculitis,2,16525492
0,22.0,Pulmonary alveolar haemorrhage,1,16525509
1,22.0,Dysgeusia,1,16525509
0,22.1,Adrenocorticotropic hormone deficiency,2,16525525
1,22.1,Hypothyroidism,2,16525525
0,22.0,Death,5,16525548
1,22.0,Malignant neoplasm progression,6,16525548
0,22.1,Emotional distress,6,16525614
1,22.1,Alopecia,2,16525614
0,22.0,Alopecia,2,16525663
0,22.1,Urinary tract infection,1,16525684
1,22.1,Hypokalaemia,1,16525684
0,22.0,Small intestine ulcer,2,16525757
0,22.0,Haematotoxicity,1,16525760
0,22.0,Foreign body in eye,1,16525776
1,22.0,Visual impairment,1,16525776
2,22.0,Cataract,1,16525776
0,22.1,Death,5,16525895
0,22.0,Cardiac failure,3,16525900
1,22.0,Pleural effusion,6,16525900
2,22.0,Malignant pleural effusion,6,16525900
3,22.0,Oedema,6,16525900
0,22.0,Death,5,16525915
0,22.0,Pneumonia,1,16526016
0,22.0,Nephrotic syndrome,6,16526069
1,22.0,Toxicity to various agents,6,16526069
0,22.0,Lung neoplasm,6,16526138
0,22.0,Decreased appetite,5,16526190
1,22.0,Oral candidiasis,5,16526190
2,22.0,Pain,5,16526190
3,22.0,Asthenia,5,16526190
4,22.0,Anaemia,5,16526190
5,22.0,Fatigue,5,16526190
6,22.0,Neoplasm progression,5,16526190
7,22.0,Lethargy,5,16526190
8,22.0,Diarrhoea,5,16526190
9,22.0,Localised infection,5,16526190
10,22.0,Weight decreased,5,16526190
11,22.0,Infection,5,16526190
12,22.0,Neutrophil count decreased,5,16526190
13,22.0,Osteoporotic fracture,5,16526190
14,22.0,Pneumonia,5,16526190
0,22.0,Death,5,16526195
0,22.1,Sepsis,5,16526199
0,22.0,Proteinuria,6,16526201
0,22.0,Neurotoxicity,2,16526208
1,22.0,Pruritus,2,16526208
0,22.0,Proteinuria,6,16526217
0,22.1,Vertigo,1,16526248
1,22.1,Angina pectoris,1,16526248
2,22.1,Blindness,4,16526248
3,22.1,Dyspnoea exertional,3,16526248
4,22.1,Headache,1,16526248
5,22.1,Polyneuropathy,3,16526248
6,22.1,Polyneuropathy,1,16526248
7,22.1,Vertigo,3,16526248
0,22.0,Dyspnoea,6,16526260
1,22.0,Muscle spasms,6,16526260
2,22.0,Dizziness,6,16526260
0,22.0,Anastomotic complication,6,16526285
1,22.0,Impaired healing,6,16526285
2,22.0,Suture rupture,6,16526285
0,22.1,Pain,6,16526296
1,22.1,Diabetes mellitus,2,16526296
2,22.1,Hypertension,3,16526296
3,22.1,Nasopharyngitis,1,16526296
4,22.1,Platelet count decreased,3,16526296
5,22.1,Fatigue,6,16526296
6,22.1,Alopecia,6,16526296
7,22.1,Stress,6,16526296
0,22.1,Cytokine release syndrome,1,16526320
0,22.0,Hypertension,1,16526322
1,22.0,Infusion related reaction,1,16526322
2,22.0,Erythema,1,16526322
0,22.0,Death,5,16526328
1,22.0,Malignant neoplasm progression,6,16526328
0,22.0,Neutropenia,1,16526354
1,22.0,Off label use,6,16526354
2,22.0,Arthralgia,1,16526354
0,22.0,Muscle rigidity,2,16526357
1,22.0,Pain,2,16526357
0,22.0,Ejection fraction decreased,6,16526358
0,22.0,Adverse event,6,16526393
0,22.0,Pyrexia,1,16526429
0,22.1,Cognitive disorder,2,16526430
1,22.1,Memory impairment,2,16526430
2,22.1,Malignant neoplasm progression,5,16526430
0,22.0,Gamma-glutamyltransferase increased,1,16526456
1,22.0,Leukopenia,1,16526456
2,22.0,Thrombocytopenia,1,16526456
3,22.0,Blood lactate dehydrogenase increased,3,16526456
0,22.0,Intestinal obstruction,6,16526498
1,22.0,Death,5,16526498
2,22.0,Intestinal perforation,6,16526498
3,22.0,Sepsis,6,16526498
0,22.0,Death,5,16526519
0,22.0,Skin discolouration,3,16526532
0,22.0,Drug resistance,6,16526538
1,22.0,Malignant neoplasm progression,6,16526538
0,22.0,Neuropathy peripheral,1,16526556
1,22.0,Nausea,1,16526556
0,22.0,Liver function test increased,6,16526599
1,22.0,Ventricular tachycardia,5,16526599
2,22.0,Cardiac failure congestive,3,16526599
0,22.0,Erythema,1,16526601
1,22.0,Infusion related reaction,1,16526601
2,22.0,Feeling hot,1,16526601
3,22.0,Hypertension,1,16526601
4,22.0,Tachycardia,1,16526601
0,22.0,Drug interaction,6,16526603
1,22.0,Transaminases increased,2,16526603
0,22.0,Hepatic function abnormal,6,16526621
1,22.0,Pigmentation disorder,6,16526621
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16526621
3,22.0,Rash,6,16526621
4,22.0,Platelet count decreased,6,16526621
5,22.0,Proteinuria,6,16526621
6,22.0,Neurotoxicity,6,16526621
7,22.0,Nausea,6,16526621
8,22.0,Vomiting,6,16526621
9,22.0,Neutrophil count decreased,6,16526621
0,22.0,Pain in extremity,3,16526653
1,22.0,Dysstasia,3,16526653
2,22.0,Gait disturbance,3,16526653
0,22.0,Injection site induration,2,16526667
1,22.0,Abscess bacterial,2,16526667
2,22.0,Injection site swelling,2,16526667
3,22.0,Injection site extravasation,6,16526667
0,22.0,Medication error,6,16526679
0,22.0,Product use in unapproved indication,6,16526692
1,22.0,Drug level increased,6,16526692
2,22.0,Drug interaction,1,16526692
3,22.0,Hypoglycaemia,1,16526692
0,22.0,Decubitus ulcer,2,16526710
1,22.0,Inappropriate schedule of product administration,6,16526710
2,22.0,Decreased appetite,2,16526710
3,22.0,Aspartate aminotransferase increased,3,16526710
4,22.0,Alanine aminotransferase increased,3,16526710
5,22.0,Hepatic enzyme increased,3,16526710
0,22.0,Drug reaction with eosinophilia and systemic symptoms,2,16526716
1,22.0,Pyrexia,1,16526716
2,22.0,Lymphopenia,1,16526716
3,22.0,Dermatitis exfoliative generalised,2,16526716
4,22.0,Odynophagia,6,16526716
5,22.0,Transaminases increased,2,16526716
6,22.0,Eosinophilia,1,16526716
7,22.0,Diarrhoea,6,16526716
0,22.0,Colitis,1,16526719
0,22.0,Malignant neoplasm progression,5,16526779
1,22.0,Hepatic infarction,5,16526779
2,22.0,Angiopathy,6,16526779
3,22.0,Myocardial infarction,5,16526779
4,22.0,Hypercoagulation,6,16526779
5,22.0,Pulmonary infarction,5,16526779
6,22.0,Multiple organ dysfunction syndrome,5,16526779
0,22.0,Coeliac disease,,16526785
0,22.1,Paronychia,1,16526815
0,22.0,Off label use,6,16526821
1,22.0,Nasopharyngitis,6,16526821
2,22.0,Diarrhoea,6,16526821
0,22.0,Dyspnoea,1,16526851
0,22.0,Metastases to lymph nodes,6,16526892
1,22.0,Feeding disorder,6,16526892
2,22.0,Hepatic cirrhosis,6,16526892
3,22.0,Fatigue,6,16526892
4,22.0,Pain,6,16526892
5,22.0,Death,5,16526892
6,22.0,Full blood count decreased,6,16526892
7,22.0,Disease progression,6,16526892
0,22.0,Neuropathy peripheral,6,16526895
0,22.0,Hypophagia,6,16526903
1,22.0,Decreased appetite,6,16526903
2,22.0,Mucosal inflammation,3,16526903
3,22.0,Vomiting,6,16526903
4,22.0,Asthenia,6,16526903
5,22.0,Hypotension,6,16526903
6,22.0,Cachexia,6,16526903
7,22.0,Nausea,6,16526903
8,22.0,General physical health deterioration,4,16526903
0,22.0,Trousseau^s syndrome,2,16526904
1,22.0,Neutropenia,1,16526904
0,22.0,Blood creatinine increased,1,16526906
1,22.0,Autoimmune hepatitis,2,16526906
2,22.0,Platelet count decreased,1,16526906
3,22.0,Neutrophil count decreased,1,16526906
4,22.0,White blood cell count decreased,1,16526906
5,22.0,Haemoglobin decreased,1,16526906
0,22.0,Neuropathy peripheral,6,16526907
1,22.0,Platelet count decreased,6,16526907
2,22.0,Paronychia,6,16526907
0,22.0,Malaise,6,16526908
0,22.0,Pain,3,16526912
1,22.0,General symptom,6,16526912
2,22.0,Mental disorder,3,16526912
0,22.0,Inappropriate schedule of product administration,6,16526931
1,22.0,Extra dose administered,6,16526931
2,22.0,Cellulitis,2,16526931
3,22.0,Confusional state,1,16526931
0,22.0,Cellulitis,6,16526940
1,22.0,Osteonecrosis of jaw,6,16526940
0,22.0,Death,5,16526993
0,22.0,Diarrhoea,6,16526996
1,22.0,Neutropenia,6,16526996
0,22.0,Diarrhoea,5,16527007
1,22.0,Ileus,5,16527007
2,22.0,Respiratory arrest,5,16527007
3,22.0,Acute kidney injury,5,16527007
4,22.0,Agranulocytosis,5,16527007
5,22.0,Infection,5,16527007
6,22.0,Cardiopulmonary failure,5,16527007
7,22.0,Bacterial infection,5,16527007
8,22.0,Neutropenia,5,16527007
0,22.0,Red blood cell count decreased,6,16527010
1,22.0,White blood cell count decreased,6,16527010
2,22.0,Pancytopenia,1,16527010
0,22.0,Leukopenia,6,16527051
1,22.0,Neutropenia,6,16527051
0,22.0,Mental disorder,6,16527084
0,22.0,Death,5,16527109
0,22.0,Death,5,16527112
1,22.0,Mucosal inflammation,5,16527112
2,22.0,Fatigue,5,16527112
0,22.0,Death,5,16527122
0,22.0,Death,5,16527123
0,22.0,Pyrexia,6,16527142
1,22.0,Metastases to liver,6,16527142
0,22.0,Gastric cancer,6,16527143
1,22.0,Metastases to liver,6,16527143
0,22.0,Femoral neck fracture,6,16527174
0,22.0,Pancytopenia,1,16527279
1,22.0,Febrile neutropenia,1,16527279
0,22.1,Diarrhoea,1,16527290
1,22.1,Erythema multiforme,1,16527290
2,22.1,Mechanical ileus,1,16527290
0,22.0,Fall,6,16527294
1,22.0,Hypokalaemia,6,16527294
2,22.0,Dizziness,6,16527294
0,22.0,Product use in unapproved indication,3,16527317
0,22.0,Neoplasm progression,4,16527326
1,22.0,Neuropathy peripheral,4,16527326
0,22.0,Drug ineffective,6,16527375
0,22.0,Metastasis,3,16527394
1,22.0,Emotional distress,3,16527394
0,22.0,Alopecia,3,16527408
0,22.0,Alopecia,2,16527409
0,22.0,Psychological trauma,6,16527477
1,22.0,Alopecia,3,16527477
0,22.0,Alopecia,2,16527498
0,22.0,Alopecia,2,16527499
1,22.0,Psychological trauma,6,16527499
0,22.0,Pancytopenia,6,16527564
0,22.0,Death,5,16527623
0,22.0,Death,5,16527624
0,22.0,Fall,6,16527650
1,22.0,General physical health deterioration,5,16527650
2,22.0,Partial seizures,3,16527650
3,22.0,Headache,3,16527650
4,22.0,Neurological decompensation,3,16527650
5,22.0,Retinal vein thrombosis,3,16527650
6,22.0,Atrial fibrillation,3,16527650
7,22.0,Optic neuropathy,3,16527650
8,22.0,Papilloedema,3,16527650
9,22.0,Subcutaneous haematoma,2,16527650
10,22.0,Hypertension,2,16527650
0,22.0,Stomatitis,6,16527652
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16527652
2,22.0,Ovarian epithelial cancer,5,16527652
3,22.0,Mucosal inflammation,6,16527652
4,22.0,Bone marrow failure,6,16527652
0,22.0,Respiratory distress,5,16527676
1,22.0,Ovarian cancer metastatic,5,16527676
2,22.0,Clostridium difficile infection,5,16527676
0,22.0,Gastrointestinal tube insertion,,16527738
1,22.0,Sepsis,3,16527738
2,22.0,Pneumonia,3,16527738
3,22.0,Off label use,,16527738
0,22.0,Chills,1,16527763
1,22.0,Abdominal distension,1,16527763
2,22.0,Rash,1,16527763
3,22.0,Rash pruritic,1,16527763
4,22.0,Erythema,1,16527763
0,22.0,Metastases to breast,6,16527776
0,22.0,Death,5,16527813
0,22.0,Gastrointestinal necrosis,5,16527816
1,22.0,Necrotising oesophagitis,5,16527816
0,22.0,Hypotension,6,16527819
1,22.0,Restlessness,6,16527819
2,22.0,Respiratory arrest,5,16527819
0,22.1,Cardiac dysfunction,2,16527820
1,22.1,Left ventricular dysfunction,2,16527820
2,22.1,Coronary artery disease,2,16527820
3,22.1,Congestive cardiomyopathy,2,16527820
4,22.1,Bundle branch block left,2,16527820
5,22.1,Cardiac failure chronic,2,16527820
6,22.1,Mitral valve incompetence,2,16527820
7,22.1,Cardiotoxicity,2,16527820
0,22.0,Band sensation,2,16527835
1,22.0,Hypotension,2,16527835
0,22.0,Neuropathy peripheral,,16527850
0,22.0,Death,5,16527872
0,22.0,Madarosis,3,16527874
1,22.0,Hair colour changes,3,16527874
2,22.0,Alopecia,3,16527874
3,22.0,Hair disorder,3,16527874
4,22.0,Hair texture abnormal,3,16527874
0,22.0,Death,5,16527877
0,22.0,Death,5,16527881
0,22.0,Death,5,16527882
0,22.0,Pathological fracture,1,16527888
0,22.0,Death,5,16528118
0,22.0,Renal arteriosclerosis,3,16528155
0,22.0,Skin lesion,6,16528173
1,22.0,Drug ineffective,6,16528173
0,22.1,Angioedema,1,16528205
1,22.1,Fall,1,16528205
2,22.1,Cataract operation,1,16528205
3,22.1,Cataract operation,1,16528205
4,22.1,Arthralgia,1,16528205
5,22.1,Malaise,1,16528205
6,22.1,Dysgeusia,3,16528205
7,22.1,Pyrexia,1,16528205
8,22.1,Nasopharyngitis,1,16528205
0,22.0,Aortic thrombosis,2,16528311
1,22.0,Musculoskeletal pain,2,16528311
2,22.0,Intermittent claudication,2,16528311
0,22.0,Asthenia,2,16528315
1,22.0,Decreased appetite,2,16528315
2,22.0,Diarrhoea,2,16528315
3,22.0,Abdominal pain,2,16528315
4,22.0,Feeling of despair,2,16528315
5,22.0,Off label use,6,16528315
0,22.0,Death,5,16528431
1,22.0,Hypertension,6,16528431
0,22.0,Hospitalisation,6,16528440
1,22.0,Gastrointestinal haemorrhage,,16528440
0,22.0,Malignant neoplasm progression,6,16528450
1,22.0,Drug resistance,6,16528450
0,22.0,Metastases to liver,6,16528509
1,22.0,Drug resistance,6,16528509
2,22.0,Malignant neoplasm progression,6,16528509
0,22.0,Breast cancer recurrent,6,16528517
0,22.0,Malignant neoplasm progression,6,16528522
1,22.0,Transaminases decreased,6,16528522
2,22.0,Drug resistance,6,16528522
0,22.0,Toxicity to various agents,6,16528530
0,22.0,Abdominal pain,3,16528537
1,22.0,Arthralgia,3,16528537
2,22.0,Fatigue,3,16528537
3,22.0,Insomnia,3,16528537
4,22.0,Malaise,3,16528537
5,22.0,Vomiting,3,16528537
6,22.0,White blood cell count decreased,3,16528537
7,22.0,Back pain,3,16528537
8,22.0,Pain in extremity,3,16528537
9,22.0,Headache,3,16528537
10,22.0,Nasopharyngitis,3,16528537
11,22.0,Bladder pain,3,16528537
12,22.0,Pulmonary embolism,3,16528537
13,22.0,Neoplasm progression,3,16528537
14,22.0,Sensory disturbance,3,16528537
15,22.0,Sleep disorder,3,16528537
0,22.0,Diarrhoea,6,16528540
1,22.0,Pulmonary embolism,6,16528540
2,22.0,Neoplasm progression,6,16528540
3,22.0,Deep vein thrombosis,6,16528540
0,22.0,White blood cell count decreased,6,16528543
1,22.0,Protein urine present,6,16528543
0,22.0,Neutropenia,1,16528551
1,22.0,Liver disorder,1,16528551
0,22.0,Cardiomyopathy,5,16528600
1,22.0,Cardiac failure,5,16528600
0,22.0,Depressed level of consciousness,3,16528601
1,22.0,General physical health deterioration,3,16528601
2,22.0,Acute respiratory distress syndrome,3,16528601
3,22.0,Cardiac failure,3,16528601
4,22.0,Toxicity to various agents,3,16528601
5,22.0,Inflammation,3,16528601
6,22.0,Bone marrow failure,3,16528601
7,22.0,Respiratory failure,3,16528601
8,22.0,Lung infiltration,3,16528601
9,22.0,Stomatitis,3,16528601
10,22.0,Diarrhoea,3,16528601
11,22.0,Blood pressure decreased,3,16528601
0,22.0,Interstitial lung disease,2,16528614
1,22.0,Pleural effusion,2,16528614
2,22.0,Pneumonia aspiration,2,16528614
3,22.0,Intentional product use issue,1,16528614
0,22.0,Poor quality sleep,3,16528672
1,22.0,Musculoskeletal chest pain,3,16528672
2,22.0,Cough,3,16528672
0,22.0,Motor dysfunction,3,16528678
1,22.0,Back pain,3,16528678
2,22.0,Diarrhoea,3,16528678
3,22.0,Neuropathy peripheral,3,16528678
4,22.0,Hypertension,3,16528678
5,22.0,Off label use,,16528678
0,22.0,Constipation,1,16528794
1,22.0,Abdominal pain,2,16528794
2,22.0,Fatigue,2,16528794
3,22.0,Peripheral swelling,3,16528794
4,22.0,Pruritus,2,16528794
5,22.0,Swelling,3,16528794
6,22.0,Flatulence,3,16528794
7,22.0,Rash generalised,3,16528794
8,22.0,Dehydration,2,16528794
9,22.0,Asthenia,2,16528794
10,22.0,Rash pruritic,3,16528794
0,22.0,Inappropriate schedule of product administration,6,16528800
1,22.0,Pneumonia,5,16528800
2,22.0,Sepsis,5,16528800
3,22.0,Malignant neoplasm progression,5,16528800
4,22.0,Adverse event,6,16528800
5,22.0,Acute kidney injury,5,16528800
6,22.0,Product use in unapproved indication,6,16528800
0,22.0,Pericardial effusion,1,16528827
0,22.1,Dry mouth,6,16528890
1,22.1,Drug ineffective,6,16528890
2,22.1,Fatigue,6,16528890
0,22.0,Vena cava thrombosis,6,16528892
0,22.1,Somnolence,5,16528921
1,22.1,Dizziness,5,16528921
2,22.1,Spinal pain,5,16528921
3,22.1,Drug interaction,6,16528921
4,22.1,Drug level decreased,6,16528921
5,22.1,Metastases to bone,5,16528921
0,22.0,Pulmonary toxicity,1,16528948
0,22.0,Off label use,6,16528975
1,22.0,Death,5,16528975
0,22.0,Pneumonia,6,16528981
1,22.0,Pain in extremity,6,16528981
2,22.0,Hypoaesthesia,6,16528981
3,22.0,Diarrhoea,6,16528981
4,22.0,White blood cell count decreased,6,16528981
0,22.0,Loss of consciousness,6,16528982
1,22.0,Multiple fractures,6,16528982
0,22.0,Pancreatitis,1,16529002
1,22.0,Hepatic function abnormal,1,16529002
2,22.0,Cholangitis sclerosing,4,16529002
0,22.0,Fatigue,6,16529008
1,22.0,Lacrimation increased,6,16529008
2,22.0,Eye pruritus,6,16529008
0,22.0,Death,5,16529011
0,22.0,Haematuria,3,16529033
1,22.0,Off label use,6,16529033
2,22.0,Pulmonary venous thrombosis,3,16529033
3,22.0,Fibrin D dimer increased,3,16529033
4,22.0,Deep vein thrombosis,3,16529033
5,22.0,Neutrophil count decreased,2,16529033
0,22.0,Death,5,16529045
1,22.0,Feeling cold,6,16529045
2,22.0,Unresponsive to stimuli,6,16529045
3,22.0,Respiratory tract congestion,6,16529045
4,22.0,General physical health deterioration,6,16529045
5,22.0,Product use in unapproved indication,6,16529045
6,22.0,Radial pulse abnormal,6,16529045
7,22.0,Flank pain,6,16529045
8,22.0,Livedo reticularis,6,16529045
0,22.0,Cancer pain,3,16529098
0,22.0,Malignant neoplasm progression,6,16529100
0,22.1,Gastroenteritis radiation,1,16529134
1,22.1,Hypoacusis,3,16529134
2,22.1,Gingival pain,1,16529134
3,22.1,Malaise,3,16529134
4,22.1,Peripheral motor neuropathy,1,16529134
5,22.1,Cellulitis,2,16529134
6,22.1,Injury,1,16529134
7,22.1,Nasopharyngitis,1,16529134
8,22.1,Menopausal symptoms,1,16529134
9,22.1,Abdominal discomfort,2,16529134
10,22.1,Nasopharyngitis,1,16529134
0,22.0,Myopia,1,16529218
1,22.0,Pneumonitis,1,16529218
2,22.0,Fatigue,3,16529218
3,22.0,Hypothyroidism,1,16529218
4,22.0,Off label use,1,16529218
5,22.0,Product use in unapproved indication,3,16529218
0,22.1,Hyperkalaemia,1,16529317
1,22.1,Disseminated intravascular coagulation,1,16529317
2,22.1,Infection,1,16529317
3,22.1,Hyperglycaemia,2,16529317
4,22.1,Constipation,2,16529317
5,22.1,Acute kidney injury,1,16529317
6,22.1,Pruritus,1,16529317
7,22.1,Rhabdomyolysis,1,16529317
8,22.1,Left ventricular dysfunction,6,16529317
9,22.1,Abdominal pain upper,2,16529317
0,22.1,Lip swelling,6,16529356
1,22.1,Lip blister,6,16529356
2,22.1,Nasopharyngitis,6,16529356
3,22.1,Epistaxis,6,16529356
4,22.1,Headache,6,16529356
5,22.1,Oral pain,6,16529356
6,22.1,Diarrhoea,6,16529356
0,22.0,Spinal pain,1,16529436
1,22.0,Drug interaction,6,16529436
2,22.0,Malignant neoplasm progression,6,16529436
0,22.1,Fulminant type 1 diabetes mellitus,2,16529450
1,22.1,Gastritis,2,16529450
2,22.1,Rash maculo-papular,2,16529450
3,22.1,Hepatic function abnormal,2,16529450
0,22.0,Bradycardia,3,16529454
0,22.1,Chronic kidney disease,3,16529525
0,22.0,Immune thrombocytopenic purpura,2,16529560
0,22.0,Chills,2,16529622
1,22.0,Hyperpyrexia,2,16529622
0,22.0,Death,5,16529643
1,22.0,Intentional product use issue,6,16529643
0,22.0,Deep vein thrombosis,2,16529644
1,22.0,Pulmonary embolism,2,16529644
0,22.0,Influenza,6,16529672
1,22.0,Cardiac disorder,6,16529672
0,22.0,Off label use,6,16529752
1,22.0,Chemotherapy,6,16529752
0,22.0,Death,5,16529765
0,22.0,Toothache,6,16529780
1,22.0,Osteonecrosis of jaw,3,16529780
2,22.0,Tooth loss,6,16529780
3,22.0,Oral infection,6,16529780
0,22.0,Breast cancer metastatic,1,16529845
1,22.0,Rash macular,1,16529845
2,22.0,Fatigue,1,16529845
3,22.0,Malignant neoplasm progression,1,16529845
0,22.1,Anaemia,1,16529885
1,22.1,Oedema peripheral,1,16529885
2,22.1,Nausea,1,16529885
3,22.1,Mucosal dryness,1,16529885
4,22.1,Off label use,6,16529885
5,22.1,Lymphoedema,1,16529885
6,22.1,Fatigue,1,16529885
7,22.1,Epistaxis,1,16529885
0,22.0,Disease progression,6,16529943
0,22.0,Haemoglobin decreased,3,16529944
1,22.0,Rash,3,16529944
2,22.0,White blood cell count decreased,3,16529944
3,22.0,Haematocrit decreased,3,16529944
0,22.0,Disease progression,6,16529946
0,22.0,Disease progression,6,16529951
0,22.0,Disease progression,6,16529955
0,22.0,Full blood count decreased,6,16529959
0,22.0,Paraneoplastic syndrome,6,16530027
1,22.0,Neuropathy peripheral,3,16530027
0,22.0,Osteonecrosis of jaw,1,16530041
0,22.0,Left ventricular dysfunction,2,16530048
1,22.0,Cardiotoxicity,2,16530048
0,22.0,Rash,6,16530091
1,22.0,Hypersensitivity,6,16530091
2,22.0,Pruritus,6,16530091
0,22.0,Septic shock,5,16530101
1,22.0,Hypertension,6,16530101
2,22.0,Respiratory failure,5,16530101
3,22.0,Pneumonia,6,16530101
4,22.0,Acidosis,6,16530101
5,22.0,White blood cell count decreased,6,16530101
6,22.0,Lymphocyte count decreased,6,16530101
7,22.0,Hyponatraemia,6,16530101
8,22.0,Neutrophil count decreased,6,16530101
9,22.0,Multiple organ dysfunction syndrome,6,16530101
10,22.0,Platelet count decreased,6,16530101
11,22.0,Cardiac arrest,5,16530101
12,22.0,Failure to thrive,6,16530101
13,22.0,Anaemia,6,16530101
0,22.0,Intentional product use issue,6,16530109
0,22.0,Disease progression,6,16530157
0,22.0,Disease progression,6,16530163
0,22.0,Disease progression,6,16530165
0,22.0,Red blood cell count decreased,6,16530247
1,22.0,Urinary tract infection,6,16530247
2,22.0,Feeling abnormal,2,16530247
3,22.0,Platelet count decreased,6,16530247
4,22.0,Vomiting,6,16530247
5,22.0,Ascites,6,16530247
6,22.0,Blood count abnormal,6,16530247
0,22.1,Prescribed underdose,6,16530292
1,22.1,Insomnia,1,16530292
2,22.1,Hyperkalaemia,1,16530292
0,22.0,Venous thrombosis limb,6,16530299
1,22.0,Pulmonary embolism,6,16530299
2,22.0,Anaemia,6,16530299
0,22.0,Cardiac pacemaker insertion,6,16530321
1,22.0,Arrhythmia,3,16530321
0,22.0,Pericarditis,2,16530328
1,22.0,Atrial fibrillation,6,16530328
2,22.0,Pericardial effusion,2,16530328
0,22.0,Malignant neoplasm progression,6,16530331
1,22.0,Drug resistance,1,16530331
2,22.0,Asthma,1,16530331
0,22.0,Pleural effusion,6,16530360
1,22.0,Pancytopenia,6,16530360
2,22.0,Neutropenia,6,16530360
3,22.0,Haematotoxicity,6,16530360
4,22.0,Ejection fraction decreased,6,16530360
0,22.0,Disease progression,6,16530375
0,22.0,Myocardial infarction,5,16530378
0,22.0,Disease progression,6,16530381
0,22.0,Disease progression,6,16530390
0,22.0,Death,5,16530393
0,22.0,Respiratory failure,5,16530395
0,22.0,Coronary artery disease,3,16530410
0,22.0,Erythema,3,16530489
1,22.0,Off label use,6,16530489
2,22.0,Generalised oedema,3,16530489
3,22.0,Pericardial effusion,3,16530489
4,22.0,Peripheral swelling,3,16530489
5,22.0,Intentional product use issue,6,16530489
0,22.0,Breast calcifications,6,16530507
1,22.0,Breast pain,6,16530507
2,22.0,Pathological fracture,6,16530507
3,22.0,Lymphadenopathy,6,16530507
4,22.0,Neoplasm progression,6,16530507
0,22.0,Drug resistance,6,16530543
1,22.0,Malignant neoplasm progression,6,16530543
0,22.0,Sensation of foreign body,4,16530547
1,22.0,Dyspnoea,4,16530547
2,22.0,Dizziness,4,16530547
3,22.0,Paraesthesia,4,16530547
0,22.0,Treatment failure,6,16530558
0,22.0,Disease progression,6,16530560
0,22.0,Off label use,6,16530604
1,22.0,Death,5,16530604
0,22.0,Leiomyoma,6,16530655
1,22.0,Ureteric obstruction,6,16530655
2,22.0,Neoplasm progression,6,16530655
3,22.0,Renal hydrocele,6,16530655
0,22.0,Myocardial infarction,5,16530684
0,22.0,Asthenia,6,16530700
1,22.0,Nausea,6,16530700
2,22.0,Death,5,16530700
3,22.0,Hallucination,6,16530700
4,22.0,Fatigue,3,16530700
5,22.0,Decreased appetite,6,16530700
6,22.0,Dizziness,6,16530700
7,22.0,Vomiting,6,16530700
8,22.0,Pain in extremity,6,16530700
0,22.0,Metastasis,3,16530711
1,22.0,Peritoneal disorder,3,16530711
2,22.0,Ovarian disorder,3,16530711
0,22.0,Dizziness,6,16530713
1,22.0,Muscle spasms,6,16530713
2,22.0,Dyspnoea,6,16530713
0,22.0,Disease progression,6,16530725
0,22.0,Feeling abnormal,6,16530731
1,22.0,Nausea,6,16530731
2,22.0,Hypervigilance,6,16530731
3,22.0,Palpitations,6,16530731
4,22.0,Somnolence,6,16530731
0,22.0,Drug ineffective,6,16530757
1,22.0,Disease recurrence,6,16530757
0,22.0,Dyspnoea,1,16530834
1,22.0,Tachycardia,1,16530834
2,22.0,Paraesthesia oral,1,16530834
0,22.0,Disease progression,6,16530852
0,22.0,Disease progression,6,16530861
0,22.0,Thyroid mass,6,16530875
1,22.0,Glucose tolerance impaired,6,16530875
2,22.0,Breast cancer,6,16530875
3,22.0,Erosive oesophagitis,6,16530875
4,22.0,Osteoporosis,6,16530875
0,22.0,Disease progression,5,16530947
0,22.0,Renal disorder,1,16530954
0,22.0,Bone marrow failure,2,16530959
0,22.1,Pruritus,6,16530968
1,22.1,Haemorrhage,6,16530968
2,22.1,Haemoglobin decreased,6,16530968
0,22.1,Radiation skin injury,1,16530971
1,22.1,Neutropenia,2,16530971
2,22.1,Skin toxicity,1,16530971
3,22.1,Neutropenia,1,16530971
4,22.1,Neutropenia,1,16530971
5,22.1,Neutropenia,1,16530971
6,22.1,Flushing,1,16530971
7,22.1,Erythema,1,16530971
8,22.1,Neutropenia,1,16530971
9,22.1,Neutropenia,1,16530971
0,22.0,Disease progression,6,16530990
0,22.0,Disease progression,6,16530993
0,22.1,White blood cell count decreased,6,16531001
1,22.1,Blood creatinine increased,1,16531001
2,22.1,Neutropenia,1,16531001
3,22.1,Carbohydrate antigen 15-3 increased,2,16531001
0,22.0,Disease progression,6,16531006
0,22.0,Disease progression,6,16531015
0,22.0,Disease progression,6,16531021
0,22.0,Disease progression,6,16531038
0,22.0,Disease progression,6,16531041
0,22.0,Disease progression,6,16531047
0,22.0,Disease progression,6,16531049
0,22.0,Arthralgia,6,16531057
1,22.0,Pain in extremity,6,16531057
2,22.0,Contusion,6,16531057
3,22.0,Thrombosis,6,16531057
0,22.0,Disease progression,6,16531059
0,22.0,Disease progression,6,16531060
0,22.0,Disease progression,6,16531068
0,22.0,Disease progression,6,16531071
0,22.0,Disease progression,6,16531075
0,22.0,Disease progression,6,16531080
0,22.0,Disease progression,6,16531081
0,22.0,Disease progression,6,16531084
0,22.0,Disease progression,6,16531085
0,22.0,Disease progression,6,16531095
0,22.0,Metastases to pelvis,6,16531100
0,22.0,Disease progression,6,16531101
0,22.0,Disease progression,6,16531102
0,22.0,Fatigue,6,16531103
1,22.0,Cardiac failure chronic,6,16531103
2,22.0,Congestive cardiomyopathy,2,16531103
3,22.0,Cough,6,16531103
0,22.0,Disease progression,6,16531108
0,22.0,Disease progression,6,16531115
0,22.0,Disease progression,6,16531121
0,22.0,Infection,6,16531145
0,22.0,Toxicity to various agents,1,16531160
1,22.0,Neoplasm progression,1,16531160
0,22.0,Constipation,1,16531161
1,22.0,Musculoskeletal pain,2,16531161
2,22.0,Haematochezia,1,16531161
3,22.0,Product dose omission,6,16531161
0,22.0,Condition aggravated,6,16531168
1,22.0,Pyrexia,6,16531168
2,22.0,Septic shock,6,16531168
3,22.0,Granulocytopenia,6,16531168
4,22.0,Neurological symptom,6,16531168
0,22.0,Death,5,16531171
0,22.0,Alanine aminotransferase increased,2,16531173
1,22.0,Aspartate aminotransferase increased,2,16531173
2,22.0,Platelet count decreased,2,16531173
3,22.0,Weight increased,2,16531173
4,22.0,Blood pressure decreased,2,16531173
5,22.0,Blood alkaline phosphatase increased,2,16531173
6,22.0,Neutrophil count decreased,2,16531173
7,22.0,Red cell distribution width increased,2,16531173
8,22.0,Blood chloride increased,2,16531173
9,22.0,White blood cell count decreased,2,16531173
0,22.1,Thrombocytopenia,1,16531178
1,22.1,Anaemia,1,16531178
0,22.0,Ejection fraction decreased,6,16531186
0,22.0,Pyrexia,6,16531198
1,22.0,Hypotension,6,16531198
2,22.0,Systemic inflammatory response syndrome,6,16531198
3,22.0,Product use in unapproved indication,6,16531198
4,22.0,Tachycardia,6,16531198
5,22.0,Off label use,6,16531198
6,22.0,Vomiting,6,16531198
7,22.0,Diarrhoea,6,16531198
0,22.0,Diplopia,3,16531222
0,22.0,Nausea,1,16531231
1,22.0,Metastases to lymph nodes,6,16531231
0,22.0,Liver disorder,6,16531242
0,22.0,Electrocardiogram QT prolonged,1,16531247
0,22.0,Neoplasm progression,6,16531248
1,22.0,Diabetes mellitus,6,16531248
2,22.0,Anaemia,6,16531248
0,22.0,Toxicity to various agents,6,16531298
0,22.0,Tumour marker increased,6,16531311
1,22.0,Metastases to abdominal cavity,6,16531311
2,22.0,Drug resistance,6,16531311
3,22.0,Ileus,5,16531311
4,22.0,Small intestinal obstruction,6,16531311
5,22.0,Hypophagia,6,16531311
6,22.0,Weight decreased,6,16531311
0,22.0,Nausea,6,16531314
1,22.0,Lung abscess,6,16531314
0,22.0,Death,5,16531316
0,22.0,Death,5,16531322
0,22.0,Melaena,1,16531332
0,22.0,Neuropathy peripheral,6,16531340
1,22.0,Dehydration,6,16531340
2,22.0,Fatigue,6,16531340
3,22.0,Balance disorder,6,16531340
4,22.0,Blood magnesium decreased,6,16531340
0,22.1,Sepsis,5,16531341
1,22.1,Febrile neutropenia,5,16531341
2,22.1,General physical health deterioration,5,16531341
3,22.1,Asthenia,5,16531341
0,22.0,Contusion,3,16531356
1,22.0,Epilepsy,1,16531356
2,22.0,Headache,3,16531356
3,22.0,Off label use,6,16531356
0,22.0,Dizziness,1,16531365
1,22.0,Malaise,1,16531365
2,22.0,Nausea,1,16531365
3,22.0,Vomiting,1,16531365
4,22.0,Diarrhoea,1,16531365
5,22.0,Vertigo,1,16531365
0,22.0,Death,5,16531367
0,22.0,Death,5,16531395
0,22.0,Dyspnoea,2,16531423
1,22.0,Orthopnoea,2,16531423
2,22.0,Pallor,2,16531423
3,22.0,Heart rate increased,2,16531423
4,22.0,Vision blurred,2,16531423
0,22.0,Prothrombin time prolonged,6,16531428
1,22.0,Haemorrhage subcutaneous,6,16531428
2,22.0,Injection site haemorrhage,1,16531428
3,22.0,Coagulation factor X level increased,6,16531428
4,22.0,Injection site bruising,1,16531428
5,22.0,Activated partial thromboplastin time prolonged,6,16531428
0,22.0,Blood pressure inadequately controlled,6,16531432
0,22.0,Deep vein thrombosis,6,16531433
0,22.0,Death,5,16531440
0,22.0,Pleural effusion,6,16531443
1,22.0,Ejection fraction decreased,6,16531443
2,22.0,Pancytopenia,6,16531443
3,22.0,Neutropenia,6,16531443
4,22.0,Haematotoxicity,6,16531443
0,22.0,Arrhythmia,6,16531444
0,22.0,Bone marrow failure,2,16531446
0,22.0,Cerebrovascular accident,6,16531447
0,22.0,Bone marrow failure,6,16531453
1,22.0,Product use in unapproved indication,6,16531453
2,22.0,Off label use,6,16531453
3,22.0,Febrile neutropenia,5,16531453
4,22.0,Renal failure,5,16531453
0,22.0,Tooth loss,6,16531457
1,22.0,Osteonecrosis of jaw,3,16531457
2,22.0,Oral infection,6,16531457
3,22.0,Toothache,6,16531457
0,22.0,Left ventricular dysfunction,6,16531468
1,22.0,Neuropathy peripheral,1,16531468
2,22.0,Mucosal inflammation,1,16531468
3,22.0,Urinary tract infection,1,16531468
4,22.0,Febrile neutropenia,1,16531468
5,22.0,Cardiotoxicity,4,16531468
0,22.0,Pain in jaw,5,16531483
1,22.0,Dehydration,5,16531483
2,22.0,Bone pain,5,16531483
3,22.0,Malaise,5,16531483
4,22.0,Death,5,16531483
0,22.0,Colitis,2,16531490
0,22.0,Alanine aminotransferase increased,3,16531506
1,22.0,Aspartate aminotransferase increased,3,16531506
0,22.1,Vomiting,1,16531513
1,22.1,Nausea,1,16531513
2,22.1,Dehydration,1,16531513
